BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 28341698)

  • 1.
    Villahermosa D; Christensen O; Knapp K; Fleck O
    G3 (Bethesda); 2017 May; 7(5):1463-1473. PubMed ID: 28341698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different frameshift mutation spectra in non-repetitive DNA of MutSalpha- and MutLalpha-deficient fission yeast cells.
    Marti TM; Mansour AA; Lehmann E; Fleck O
    DNA Repair (Amst); 2003 May; 2(5):571-80. PubMed ID: 12713814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA mismatch repair and mutation avoidance pathways.
    Marti TM; Kunz C; Fleck O
    J Cell Physiol; 2002 Apr; 191(1):28-41. PubMed ID: 11920679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reconstitution of
    Bowen N; Kolodner RD
    Proc Natl Acad Sci U S A; 2017 Apr; 114(14):3607-3612. PubMed ID: 28265089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of the DNA repair nucleases Rad13, Rad2 and Uve1 of Schizosaccharomyces pombe in mismatch correction.
    Kunz C; Fleck O
    J Mol Biol; 2001 Oct; 313(2):241-53. PubMed ID: 11800554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Control of GT repeat stability in Schizosaccharomyces pombe by mismatch repair factors.
    Mansour AA; Tornier C; Lehmann E; Darmon M; Fleck O
    Genetics; 2001 May; 158(1):77-85. PubMed ID: 11333219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated MSH2 MSH3 expression interferes with DNA metabolism in vivo.
    Medina-Rivera M; Phelps S; Sridharan M; Becker J; Lamb NA; Kumar C; Sutton MD; Bielinsky A; Balakrishnan L; Surtees JA
    Nucleic Acids Res; 2023 Dec; 51(22):12185-12206. PubMed ID: 37930834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic validation of MMR-associated genetic modifiers in a human ex vivo model of Huntington disease.
    Ferguson R; Goold R; Coupland L; Flower M; Tabrizi SJ
    Am J Hum Genet; 2024 Jun; 111(6):1165-1183. PubMed ID: 38749429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mispair-specific recruitment of the Mlh1-Pms1 complex identifies repair substrates of the Saccharomyces cerevisiae Msh2-Msh3 complex.
    Srivatsan A; Bowen N; Kolodner RD
    J Biol Chem; 2014 Mar; 289(13):9352-64. PubMed ID: 24550389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of DNA mismatch repair in the maintenance of heterochromatic DNA stability in Saccharomyces cerevisiae.
    Dahal BK; Kadyrova LY; Delfino KR; Rogozin IB; Gujar V; Lobachev KS; Kadyrov FA
    PLoS Genet; 2017 Oct; 13(10):e1007074. PubMed ID: 29069084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of Saccharomyces cerevisiae Mlh1-Pms1 Endonuclease in a Reconstituted Mismatch Repair System.
    Smith CE; Bowen N; Graham WJ; Goellner EM; Srivatsan A; Kolodner RD
    J Biol Chem; 2015 Aug; 290(35):21580-90. PubMed ID: 26170454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MutSbeta exceeds MutSalpha in dinucleotide loop repair.
    Kantelinen J; Kansikas M; Korhonen MK; Ollila S; Heinimann K; Kariola R; Nyström M
    Br J Cancer; 2010 Mar; 102(6):1068-73. PubMed ID: 20160730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MutSα deficiency increases tolerance to DNA damage in yeast lacking postreplication repair.
    Berg IL; Persson JO; Åström SU
    DNA Repair (Amst); 2020; 91-92():102870. PubMed ID: 32470850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disease-associated repeat instability and mismatch repair.
    Schmidt MHM; Pearson CE
    DNA Repair (Amst); 2016 Feb; 38():117-126. PubMed ID: 26774442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MutLγ promotes repeat expansion in a Fragile X mouse model while EXO1 is protective.
    Zhao X; Zhang Y; Wilkins K; Edelmann W; Usdin K
    PLoS Genet; 2018 Oct; 14(10):e1007719. PubMed ID: 30312299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differing patterns of genetic instability in mice deficient in the mismatch repair genes Pms2, Mlh1, Msh2, Msh3 and Msh6.
    Hegan DC; Narayanan L; Jirik FR; Edelmann W; Liskay RM; Glazer PM
    Carcinogenesis; 2006 Dec; 27(12):2402-8. PubMed ID: 16728433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MSH3 mismatch repair protein regulates sensitivity to cytotoxic drugs and a histone deacetylase inhibitor in human colon carcinoma cells.
    Park JM; Huang S; Tougeron D; Sinicrope FA
    PLoS One; 2013; 8(5):e65369. PubMed ID: 23724141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ATP binding and hydrolysis by Saccharomyces cerevisiae Msh2-Msh3 are differentially modulated by mismatch and double-strand break repair DNA substrates.
    Kumar C; Eichmiller R; Wang B; Williams GM; Bianco PR; Surtees JA
    DNA Repair (Amst); 2014 Jun; 18():18-30. PubMed ID: 24746922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of MSH2 and MSH6 due to heterozygous germline defects in MSH3 and MSH6.
    Morak M; Käsbauer S; Kerscher M; Laner A; Nissen AM; Benet-Pagès A; Schackert HK; Keller G; Massdorf T; Holinski-Feder E
    Fam Cancer; 2017 Oct; 16(4):491-500. PubMed ID: 28528517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamic human MutSα-MutLα complexes compact mismatched DNA.
    Bradford KC; Wilkins H; Hao P; Li ZM; Wang B; Burke D; Wu D; Smith AE; Spaller L; Du C; Gauer JW; Chan E; Hsieh P; Weninger KR; Erie DA
    Proc Natl Acad Sci U S A; 2020 Jul; 117(28):16302-16312. PubMed ID: 32586954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.